Literature DB >> 11111952

Immunobiology of xenotransplantation.

J L Platt1.   

Abstract

The transplantation of organs between disparate species is hindered by severe immune responses of the recipient against the graft. These immune responses gives rise to hyperacute and acute vascular rejection and to cellular rejection. Research during the past decade has shed light on the elements of the immune system responsible for the rejection of xenografts and has provided novel and incisive therapies which might be applied to these problems.

Mesh:

Substances:

Year:  2000        PMID: 11111952     DOI: 10.1007/s001470050265

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

Review 1.  Encapsulated cell grafts to treat cellular deficiencies and dysfunction.

Authors:  N V Krishnamurthy; Barjor Gimi
Journal:  Crit Rev Biomed Eng       Date:  2011

2.  Xenogeneic islet transplantation of microencapsulated porcine islets for therapy of type I diabetes: long-term normoglycemia in STZ-diabetic rats without immunosuppression.

Authors:  Thomas Meyer; Burkhard Höcht; Karin Ulrichs
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

3.  Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses.

Authors:  Yih-Jyh Lin; Hidetaka Hara; Hao-Chih Tai; Cassandra Long; Daisuke Tokita; Peter Yeh; David Ayares; Adrian E Morelli; David K C Cooper
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

4.  Immune responses following mouse peripheral nerve xenotransplantation in rats.

Authors:  Lai-Jin Lu; Jia-Bing Sun; Zhi-Gang Liu; Xu Gong; Jian-Li Cui; Xi-Guang Sun
Journal:  J Biomed Biotechnol       Date:  2009-10-12

5.  Xenograft tolerance and immune function of human T cells developing in pig thymus xenografts.

Authors:  Hannes Kalscheuer; Takashi Onoe; Alexander Dahmani; Hao-Wei Li; Markus Hölzl; Kazuhiko Yamada; Megan Sykes
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

Review 6.  Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate.

Authors:  William L Fodor
Journal:  Reprod Biol Endocrinol       Date:  2003-11-13       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.